´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¼¿ï/°æÀÎÁöȸ ÇÕµ¿ Áý´ãȸ
|
ÁÖ ÃÖ: ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¼¿ï/°æÀÎÁöȸ
ÀÏ ½Ã: 2013³â 1¿ù 15 ÀÏ (È) 18:20 ~21:00
Àå ¼Ò: °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç
´ë »ó: ³»°ú, ¼Ò¾ÆÃ»¼Ò³â°ú, À̺ñÀÎÈİú, ÇǺΰú Àü¹®ÀÇ, ÀüÀÓÀÇ, Àü°øÀÇ
¿¬¼öÆòÁ¡: 2Á¡ |
´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¼¿ï/°æÀÎÁöȸ ÇÕµ¿ Áý´ãȸ¿¡ ¼±»ý´ÔÀ» ÃÊ´ëÇÕ´Ï´Ù. À̹ø¿¡´Â ƯÈ÷ ¼¿ïÁöȸ¿Í °æÀÎÁöȸ ȸ¿ø´ÔµéÀÇ ÇÕµ¿ Áý´ãȸ¸¦ °³ÃÖÇÕ´Ï´Ù. Ư°Àº ¼¿ïÀÇ´ë »ý¸®Çб³½Ç ±è¼ºÁØ ±³¼ö´ÔÀ» ¸ð½Ã°í, 'Role of ion channels and Ca2+ signaling in immune cells associated with allergic disease
'¸¦ ¸¶·ÃÇÏ¿´°í, 4°³ÀÇ Áõ·ÊÅäÀÇ ¿ª½Ã Èï¹Ì·Ó°í À¯ÀÍÇÏ°Ô ÁغñÇÏ¿´½À´Ï´Ù. ¸¹Àº ºÐµéÀÌ Âü¼®ÇϽþî Áöȸ¿øµé °£¿¡ Ä£¸ñÀ» µµ¸ðÇÏ°í ¾Æ¿ï·¯ ÁÁÀº Åä·ÐÀÇ ÀåÀÌ µÇ±â¸¦ ¹Ù¶ø´Ï´Ù. ¸¹Àº Âü¼® ºÎʵ右´Ï´Ù.
|
17:30-18:20 |
µî·Ï, Àú³á ½Ä»ç |
18:20–18:30 |
ÁöȸÀå´Ô Àλ縻¾¸ |
18:30–19:10 |
Ư° |
|
Á¦¸ñ: Role of ion channels and Ca2+ signaling in immune cells associated with allergic disease
¹ßÇ¥: ¼¿ïÀÇ´ë »ý¸®Çб³½Ç ±è¼ºÁØ |
|
19:10–19:20 |
Break |
19:20-20:50 |
1) IgG4 related sclerosing disease (IgG4 related RD) |
|
¹ßÇ¥: ¾ÆÁÖÀÇ´ë ³»°ú ÀÌ¿µ¼ö
ÁöÁ¤Åä·Ð: ¾ÆÁÖÀÇ´ë ³»°ú ½ÅÀ¯¼· |
2) ±¹¼Ò ¾Ë·¹¸£±âºñ¿°: Áõ·Êº¸°í ¹× ÀÓ»óÀû/¸é¿ªÇÐÀû Ư¼º °íÂû |
|
¹ßÇ¥: ÀÎÇÏÀÇ´ë À̺ñÀÎÈİú ±è¿µÈ¿
ÁöÁ¤Åä·Ð: ÀÎÇÏÀÇ´ë À̺ñÀÎÈİú ±è¿µÈ¿ |
3) Airway malacia as a cause of recurrent wheezing |
|
¹ßÇ¥: °¡Å縯ÀÇ´ë ¼Ò¾ÆÃ»¼Ò³â°ú ·ùÁö¿õ
ÁöÁ¤Åä·Ð: °¡Å縯ÀÇ´ë ¼Ò¾ÆÃ»¼Ò³â°ú Á¤¿ìÁø |
4) A case of psoriasiform eruption after adalimumab injection for treatment of ankylosing spondylitis |
|
¹ßÇ¥: °Ç±¹ÀÇ´ë ÇǺΰú ÇÑÇüÁø
ÁöÁ¤Åä·Ð: °Ç±¹ÀÇ´ë ÇǺΰú ÀÌ¾ç¿ø |
|
* Áý´ãȸ ½ÃÀÛÀüÀÎ ¿ÀÈÄ 5:30ºÐºÎÅÍ ½Ä»ç°¡ Áغñ µË´Ï´Ù.
|